Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant ERG anticorps (C-Term)

Cet anticorps Lapin Monoclonal détecte spécifiquement ERG dans IHC (f). Il présente une réactivité envers Humain.
N° du produit ABIN7126343

Aperçu rapide pour Recombinant ERG anticorps (C-Term) (ABIN7126343)

Antigène

Voir toutes ERG Anticorps
ERG (ERG, ETS transcription factor (ERG))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 59
  • 35
  • 34
  • 7
  • 6
  • 6
  • 6
  • 5
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Humain

Hôte

  • 50
  • 9
  • 1
Lapin

Clonalité

  • 42
  • 18
Monoclonal

Conjugué

  • 37
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Cet anticorp ERG est non-conjugé

Application

  • 36
  • 21
  • 16
  • 15
  • 10
  • 8
  • 6
  • 2
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Épitope

    • 8
    • 6
    • 5
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term

    Specificité

    ERG (ETS-related gene) is a proto-oncogene, a member of the ETS family of transcription factors. The ERG gene encodes for a nuclear protein, also called ERG, which is involved in hematopoietic and endothelial development. ERG remains constitually expressed in endothelial cells in blood and lymphatic vessels, and in bone marrow stem cells. ERG is expressed in virtually all endothelial neoplasms including hemangioendothelioma, angiosarcoma and Kaposi sarcoma. ERG is overexpressed secondary to gene rearrangement in cases of prostate adenocarcinoma, gastrointestinal stromal tumor, synovial sarcoma, meningioma, epithelioid sarcoma, malignant rhabdoid tumor, acute myeloid leukemia and blastic extramedullary myeloid tumor, and rarely Ewing sarcoma / primitive peripheral neuroectodermal tumor, chondrosarcoma, osteosarcoma, and rhabdomyosarcoma. For the identification of endothelial differentiation ERG seems more sensitive and specific than any other marker. Moreover, the interpretation is often easier due to the nuclear reaction, which also allows for double stains with cytoplasmic markers like podoplanin. Among carcinomas, ERG is highly specific for prostate, while the sensitivity is moderate.

    Réactivité croisée (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Synthetic peptide corresponding to residues within aa450 to C-terminus of ERG was used as an immunogen.

    Isotype

    IgG
  • Indications d'application

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Positive_Control: Human tonsil, Ewing sarcoma or prostate adenocarcinoma tissues.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    ERG (ERG, ETS transcription factor (ERG))

    Autre désignation

    ERG

    Sujet

    ERG, ERG/EWS fusion gene, ERG/FUS fusion gene, ERG/TMPSSR2 fusion gene, ERG1, ETS-related, KCNH2, Oncogene ERG, p55, TMPRSS2/ERG fusion,ERG (Vascular Endothelial & Prostate Marker)
    Cellular localisation: Nucleus.

    Poids moléculaire

    55kDa

    ID gène

    2078, 473819

    UniProt

    P11308
Vous êtes ici:
Chat with us!